Oramed Pharmaceuticals (ORMP) Q2 2026 Earnings

19MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.19
0.18
0.54
0.91

Details

Expected EPS
N/A
Actual EPS
0.91
Surprise EPS
0.91
Surprise Percent
+∞%

Description

Oramed Pharmaceuticals (ORMP) has reported earnings of 0.91 per share for Q2 2026.

0 Comments

Share your thoughts